- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
New House GOP Budget AgainTakes Aim at Obamacare, Medicaid, Would Lead to Balance in 10 Years
WASHINGTON — House Republicans are sticking to their guns on the federal budget, promising to try to repeal so-called Obamacare, cut domestic programs from Medicaid to college grants and require future Medicare patients to bear more of the program’s cost.
The point is to prove it’s possible to balance the budget within 10 years by simply cutting spending and avoiding further tax hikes, even as the fiscal blueprint to be released Tuesday by Budget Committee Chairman Paul Ryan, R-Wis., will be dead on arrival with the White House and Democrats controlling the Senate.
Read the full story: http://wapo.st/YVbvYv
Source: The Washington Post
Trump Administration’s Message to Supreme Court Puts New Wrinkle in Braidwood Case
February 21st 2025The Trump administration argues that HHS Secretary Robert F. Kennedy Jr can overrule the US Preventive Services Task Force to determine the preventive services covered under the Affordable Care Act.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
5 Key Health Care Moments During President Trump's First Month Back in Office
February 21st 2025President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive orders affecting managed care, drug pricing, and clinical trial diversity guidance.
Read More
Abortion in 2025: Access, Fertility, and Infant Mortality Updates
February 20th 2025While Republican state-led efforts aim to increase restrictions to abortion care and access to mifepristone and misoprostol in 2025, JAMA authors join the conversation with their published research and commentary.
Read More
